These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 9571178)

  • 1. Expression of a hepatitis C virus NS3 protease-NS4A fusion protein in Escherichia coli.
    Inoue H; Sakashita H; Shimizu Y; Yamaji K; Yokota T; Sudo K; Shigeta S; Shimotohno K
    Biochem Biophys Res Commun; 1998 Apr; 245(2):478-82. PubMed ID: 9571178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and purification of an active, full-length hepatitis C viral NS4A.
    Back SH; Kim JE; Rho J; Hahm B; Lee TG; Kim EE; Cho JM; Jang SK
    Protein Expr Purif; 2000 Nov; 20(2):196-206. PubMed ID: 11049744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of hepatitis C virus NS3 protease and helicase activities through the interaction with NS4A.
    Gallinari P; Paolini C; Brennan D; Nardi C; Steinkühler C; De Francesco R
    Biochemistry; 1999 Apr; 38(17):5620-32. PubMed ID: 10220351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of the fused NS4A peptide-NS3 protease domain to study the importance of the helicase domain for protease inhibitor binding to hepatitis C virus NS3-NS4A.
    Thibeault D; Massariol MJ; Zhao S; Welchner E; Goudreau N; Gingras R; Llinàs-Brunet M; White PW
    Biochemistry; 2009 Feb; 48(4):744-53. PubMed ID: 19119853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serine protease of hepatitis C virus expressed in insect cells as the NS3/4A complex.
    Sali DL; Ingram R; Wendel M; Gupta D; McNemar C; Tsarbopoulos A; Chen JW; Hong Z; Chase R; Risano C; Zhang R; Yao N; Kwong AD; Ramanathan L; Le HV; Weber PC
    Biochemistry; 1998 Mar; 37(10):3392-401. PubMed ID: 9521660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzymatic characterization of purified NS3 serine proteinase of hepatitis C virus expressed in Escherichia coli.
    Mori A; Yamada K; Kimura J; Koide T; Yuasa S; Yamada E; Miyamura T
    FEBS Lett; 1996 Jan; 378(1):37-42. PubMed ID: 8549798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virus-specific cofactor requirement and chimeric hepatitis C virus/GB virus B nonstructural protein 3.
    Butkiewicz N; Yao N; Zhong W; Wright-Minogue J; Ingravallo P; Zhang R; Durkin J; Standring DN; Baroudy BM; Sangar DV; Lemon SM; Lau JY; Hong Z
    J Virol; 2000 May; 74(9):4291-301. PubMed ID: 10756044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the sequence on NS4A required for enhanced cleavage of the NS5A/5B site by hepatitis C virus NS3 protease.
    Shimizu Y; Yamaji K; Masuho Y; Yokota T; Inoue H; Sudo K; Satoh S; Shimotohno K
    J Virol; 1996 Jan; 70(1):127-32. PubMed ID: 8523516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple enzymatic activities associated with recombinant NS3 protein of hepatitis C virus.
    Gallinari P; Brennan D; Nardi C; Brunetti M; Tomei L; Steinkühler C; De Francesco R
    J Virol; 1998 Aug; 72(8):6758-69. PubMed ID: 9658124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Processing of hepatitis C viral polyprotein in Escherichia coli.
    Komoda Y; Hijikata M; Tanji Y; Hirowatari Y; Mizushima H; Kimura K; Shimotohno K
    Gene; 1994 Aug; 145(2):221-6. PubMed ID: 8056335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering, characterization and phage display of hepatitis C virus NS3 protease and NS4A cofactor peptide as a single-chain protein.
    Dimasi N; Pasquo A; Martin F; Di Marco S; Steinkühler C; Cortese R; Sollazzo M
    Protein Eng; 1998 Dec; 11(12):1257-65. PubMed ID: 9930676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of an in vitro assay system for screening hepatitis C virus protease inhibitors using high performance liquid chromatography.
    Sudo K; Inoue H; Shimizu Y; Yamaji K; Konno K; Shigeta S; Kaneko T; Yokota T; Shimotohno K
    Antiviral Res; 1996 Aug; 32(1):9-18. PubMed ID: 8863991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An uniquely purified HCV NS3 protease and NS4A(21-34) peptide form a highly active serine protease complex in peptide hydrolysis.
    Sardana VV; Blue JT; Zugay-Murphy J; Sardana MK; Kuo LC
    Protein Expr Purif; 1999 Aug; 16(3):440-7. PubMed ID: 10425166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction, expression, and characterization of a novel fully activated recombinant single-chain hepatitis C virus protease.
    Taremi SS; Beyer B; Maher M; Yao N; Prosise W; Weber PC; Malcolm BA
    Protein Sci; 1998 Oct; 7(10):2143-9. PubMed ID: 9792101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanistic role of an NS4A peptide cofactor with the truncated NS3 protease of hepatitis C virus: elucidation of the NS4A stimulatory effect via kinetic analysis and inhibitor mapping.
    Landro JA; Raybuck SA; Luong YP; O'Malley ET; Harbeson SL; Morgenstern KA; Rao G; Livingston DJ
    Biochemistry; 1997 Aug; 36(31):9340-8. PubMed ID: 9235976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An amino-terminal domain of the hepatitis C virus NS3 protease is essential for interaction with NS4A.
    Failla C; Tomei L; De Francesco R
    J Virol; 1995 Mar; 69(3):1769-77. PubMed ID: 7853516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular views of viral polyprotein processing revealed by the crystal structure of the hepatitis C virus bifunctional protease-helicase.
    Yao N; Reichert P; Taremi SS; Prosise WW; Weber PC
    Structure; 1999 Nov; 7(11):1353-63. PubMed ID: 10574797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Both NS3 and NS4A are required for proteolytic processing of hepatitis C virus nonstructural proteins.
    Failla C; Tomei L; De Francesco R
    J Virol; 1994 Jun; 68(6):3753-60. PubMed ID: 8189513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The design and synthesis of potent inhibitors of hepatitis C virus NS3-4A proteinase.
    Attwood MR; Bennett JM; Campbell AD; Canning GG; Carr MG; Conway E; Dunsdon RM; Greening JR; Jones PS; Kay PB; Handa BK; Hurst DN; Jennings NS; Jordan S; Keech E; O'Brien MA; Overton HA; King-Underwood J; Raynham TM; Stenson KP; Wilkinson CS; Wilkinson TC; Wilson FX
    Antivir Chem Chemother; 1999 Sep; 10(5):259-73. PubMed ID: 10574181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Selection and characterization of peptides that specifically binding to hepatitis C virus serine protease].
    Du G; Hou L; Chen W; Zhang Y; Wang H
    Wei Sheng Wu Xue Bao; 2002 Jun; 42(3):298-304. PubMed ID: 12557369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.